Kazia Therapeutics Ltd - Company Profile
Powered by 
All the sales intelligence you need on Kazia Therapeutics Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Kazia Therapeutics Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Kazia Therapeutics Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Kazia Therapeutics Limited (Kazia), is an Australian biotechnology company. Focused research and development activities and its lead product candidate Paxalisib are its key strengths, even as the history of operating losses is an area of concern to the company. Stringent regulations, competitive pressures, and intellectual property and patent risks could hurt Kazia's business and operating results. However, the unmet medical need for ovarian cancer, strategic agreements and launch of new products could present ample growth opportunities to the company.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer